Eneda is Director of IP for ReCode Therapeutics, the first genetic medicines platform to enable highly targeted delivery to organs, tissues, and cells beyond the liver. Eneda began her legal career at Morrison and Foerster’s patent group, where she worked on patent prosecution and strategy matters. She then joined Durie Tangri, and later Latham and Watkins, where she worked on IP litigation matters for companies ranging from small startups to the most successful biotechnology companies in the world.
Prior to law school, Eneda was a scientist and process engineer for Cellular Dynamics International Inc., where she worked on stem cell regulation and differentiation into the cardiovascular lineage. She received her Ph.D. from Northwestern University’s Feinberg School of Medicine in biomedical sciences. Eneda earned her J.D. at the University of California, Berkeley– School of Law.
In her free time Eneda enjoys spending time with her family, baking, knitting, artisanal cheese making, and skiing.
JD, UC Berkeley (2016)
PhD, Northwestern University (2012)